The company is adding new capabilities of Combi-line for Microsphere, additional Bag line and lyos for the Penem block in Pashamylaram facility in Hyderabad and will be earmarking capital for further building on its Biosimilar CDMO facility Gland Pharma Limited, a generic injectable focused pharmaceutical company, has closed the third quarter and nine months ended December 31, 2022 with revenues of Rs
We have witnessed improved joint mobility in patients using GLP-1 therapy, offering a comprehensive approach to managing joint pain alongside other metabolic benefits
Biochemical Basis of Cellular Aging and Oxidative Stress Reactive Oxygen Species (ROS) continuously attack DNA, lipids, and proteins
Natco Pharma is expected to be one of the first entrants into the semaglutide generics market by March 2026, while Cipla is working on innovative oral GLP-1 formulations that could revolutionize the market
This ensures patients stay safe and get the best results
Youll also need tests before you start the medicine
